News & publications > News > Atlantis Healthcare and Bayer Pharmaceuticals awarded at the 2019 PRIME Awards in “Sustained Excelle

Atlantis Healthcare and Bayer Pharmaceuticals awarded at the 2019 PRIME Awards in “Sustained Excellence in Bettering Patient Outcomes”

Tuesday, 01 October 2019
 
Atlantis Healthcare Australia (AHA), a pioneer and global leader in health psychology-based patient support programs, and Bayer Pharmaceuticals Australia, have been awarded a highly commended in the 2019 PRIME Awards “Sustained excellence in better patient outcomes” category.

The award was presented for the SmartSight patient support program, which supports patients undergoing treatment for wet age-related macular degeneration (wAMD) or diabetic macular oedema (DMO). SmartSight was established in 2012 with Atlantis Healthcare appointed to oversee the management and delivery of the service.

The innovative program incorporates elements of motivational interviewing and behaviour change techniques that identify and address individual patients’ concerns and needs around their treatment.

“We are honoured to partner with Bayer to not only be awarded another PRIME Award, but to deliver better health outcomes for patients enrolled in the Smartsight program,” said Connor Holmes, Country Manager for Atlantis Healthcare Australia.

 “Through innovation and health psychology, we’ve partnered with Bayer to continually assess the program’s impacts and enhance the service offering, leading to service improvements year on year.”
Each year the PRIME Awards recognise outstanding achievement and innovation in healthcare across Australia, with submissions judged by a distinguished panel of industry experts. Bayer and Atlantis Healthcare’s entry was one of 58 finalists chosen across 17 Initiative categories, with Bayer also a finalist in the “GPs' Choice: Pharma Company of the Year” category.

“Bayer is extremely proud of the patient-centric support program SmartSight has grown to be and thrilled that the PRIME Awards has recognised this. We’d like to acknowledge and thank all the dedicated people who have helped make SmartSight a big win for patients, including the Atlantis Healthcare team, healthcare professionals and our community partners. Together, we’ve developed a program that is truly enhancing patient outcomes” Peter Said, Head of Patient Engagement ANZ


About Atlantis Healthcare
Atlantis Healthcare leverages the latest health psychology and behavioural science to develop and deliver personalised, cost-effective solutions for healthcare customers and consumers to improve outcomes and experiences. We work with leading pharmaceutical/biotech brands, payers and healthcare institutions on regional and global programs from hubs in US, UK, Germany, Australia and New Zealand.
 

About Atlantis Healthcare Group

Atlantis Healthcare leverages health psychology to develop and deliver uniquely personalized healthcare solutions that drive sustained improvement in patient outcome through self-management and treatment adherence across chronic diseases.

With the largest team of globally recognized health psychology experts in a commercial setting, supported by digital creative experts, Atlantis Healthcare uses clinically proven models and academic research to develop award-winning behavior change programs, helping patients achieve better health outcomes. The group provides solutions and services across the globe from offices in UK, Germany, US, Australia and New Zealand.